These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1560 related items for PubMed ID: 9341744
1. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites. Bergmann ES, Ballou RW, Krzych U. Cell Immunol; 1997 Sep 15; 180(2):143-52. PubMed ID: 9341744 [Abstract] [Full Text] [Related]
2. T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens. Krzych U, Lyon JA, Jareed T, Schneider I, Hollingdale MR, Gordon DM, Ballou WR. J Immunol; 1995 Oct 15; 155(8):4072-7. PubMed ID: 7561118 [Abstract] [Full Text] [Related]
3. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection. Cummings JF, Spring MD, Schwenk RJ, Ockenhouse CF, Kester KE, Polhemus ME, Walsh DS, Yoon IK, Prosperi C, Juompan LY, Lanar DE, Krzych U, Hall BT, Ware LA, Stewart VA, Williams J, Dowler M, Nielsen RK, Hillier CJ, Giersing BK, Dubovsky F, Malkin E, Tucker K, Dubois MC, Cohen JD, Ballou WR, Heppner DG. Vaccine; 2010 Jul 12; 28(31):5135-44. PubMed ID: 19737527 [Abstract] [Full Text] [Related]
4. Cellular and molecular requirements for the recall of IL-4-producing memory CD4(+)CD45RO(+)CD27(-) T cells during protection induced by attenuated Plasmodium falciparum sporozoites. Palmer DR, Krzych U. Eur J Immunol; 2002 Mar 12; 32(3):652-61. PubMed ID: 11857339 [Abstract] [Full Text] [Related]
5. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei. White KL, Snyder HL, Krzych U. J Immunol; 1996 May 01; 156(9):3374-81. PubMed ID: 8617963 [Abstract] [Full Text] [Related]
6. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children. Høgh B. Scand J Infect Dis Suppl; 1996 May 01; 102():1-53. PubMed ID: 9060051 [Abstract] [Full Text] [Related]
7. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites. Meraldi V, Romero JF, Kensil C, Corradin G. Vaccine; 2005 Apr 15; 23(21):2801-12. PubMed ID: 15780728 [Abstract] [Full Text] [Related]
14. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling. Cai Q, Peng G, Bu L, Lin Y, Zhang L, Lustigmen S, Wang H. Vaccine; 2007 Jul 09; 25(28):5155-65. PubMed ID: 17548134 [Abstract] [Full Text] [Related]
15. Production of IL 2 and IFN-gamma by T cells from malaria patients in response to Plasmodium falciparum or erythrocyte antigens in vitro. Troye-Blomberg M, Andersson G, Stoczkowska M, Shabo R, Romero P, Patarroyo ME, Wigzell H, Perlmann P. J Immunol; 1985 Nov 09; 135(5):3498-504. PubMed ID: 3930605 [Abstract] [Full Text] [Related]
16. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. Gazzinelli RT, Hakim FT, Hieny S, Shearer GM, Sher A. J Immunol; 1991 Jan 01; 146(1):286-92. PubMed ID: 1670604 [Abstract] [Full Text] [Related]
17. Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children. D'Ombrain MC, Robinson LJ, Stanisic DI, Taraika J, Bernard N, Michon P, Mueller I, Schofield L. Clin Infect Dis; 2008 Dec 01; 47(11):1380-7. PubMed ID: 18947328 [Abstract] [Full Text] [Related]
19. A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses. Prieur E, Gilbert SC, Schneider J, Moore AC, Sheu EG, Goonetilleke N, Robson KJ, Hill AV. Proc Natl Acad Sci U S A; 2004 Jan 06; 101(1):290-5. PubMed ID: 14694197 [Abstract] [Full Text] [Related]